Compare ResMed Inc. (RMD) vs Unum Group Common Stock (UNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Unum Group Common Stock — how do they compare? ResMed Inc. trades at $236.19 (market cap $33.09B), while Unum Group Common Stock trades at $91.42 (market cap $14.48B). The key difference: ResMed Inc. is far larger — about 2.3× Unum Group Common Stock's market cap, and Unum Group Common Stock pays the higher dividend (2.21%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Unum Group Common Stock for 0 Days on average.
| RMD | UNM | |
|---|---|---|
Market Cap | $33.09B | $14.48B |
Volume | 1,019,685 | 2,214,044 |
Sector | Health | Financials |
52-Week High | $275.96 | $96.57 |
52-Week Low | $182.82 | $70.66 |
Typical Hold Time | 51 Days | 0 Days |
Enterprise Value | $32.45B | $18.04B |
Dividend Yield | 1.12% | 2.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $235.04, up 0.19% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $243.56. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.95 exceeding expectations. Revenue grew to $5.15B in 2025, with a robust net income margin of 26.94%, while cash flow from operations reached $1.75B. Recent news highlights upcoming Q1 2027 earnings and a Morgan Stanley conference presentation focusing on growth targets.
The outlook for RMD is positive, driven by consistent earnings outperformance, high profitability, and institutional buying interest. Key opportunities include market share gains and product innovation in sleep therapy, though risks involve competitive pressures and ongoing legal investigations. The stock's current valuation metrics, including a P/E of 22.56, appear reasonable relative to growth, supporting a constructive view for investors seeking exposure to healthcare equipment.
Unum Group (UNM) trades at $92.05, down 0.5% with neutral technical signals. The stock shows mixed earnings performance with Q1 2026 beating estimates but Q4 2025 and Q2 2026 missing expectations. Analyst consensus is positive with 50% buy ratings and a $101 price target representing 9.7% upside. The company maintains stable profitability with 5.31% net margin and recently announced a $1 billion share repurchase program to enhance shareholder returns.
UNM presents a balanced investment case with strong institutional support and shareholder-friendly capital returns, though earnings consistency remains a concern. The stock trades at reasonable valuations (P/E 21.36, P/S 1.15) with potential upside to analyst targets. Key risks include premium growth sustainability and claims experience volatility in the insurance operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Unum Group Common Stock
Unum Group provides workplace benefits, including disability, life, accident, critical illness, dental, and vision insurance, along with leave management services. It serves employers through its Unum US, Unum International, and Colonial Life segments, distributing coverage via brokers and independent agents.
Read more on UNM →
